129 related articles for article (PubMed ID: 37300942)
1. Toward a theranostic device for gliomas.
Paradossi G; Grossman R; Riccitelli F; Todaro F; Ram Z; Schioppa S; Domenici F
Biochem Biophys Res Commun; 2023 Sep; 671():124-131. PubMed ID: 37300942
[TBL] [Abstract][Full Text] [Related]
2. PVA-Microbubbles as a Radioembolization Platform: Formulation and the In Vitro Proof of Concept.
Da Ros V; Oddo L; Toumia Y; Guida E; Minosse S; Strigari L; Strolin S; Paolani G; Di Giuliano F; Floris R; Garaci F; Dolci S; Paradossi G; Domenici F
Pharmaceutics; 2023 Jan; 15(1):. PubMed ID: 36678846
[TBL] [Abstract][Full Text] [Related]
3. RGD-Targeted Ultrasound Contrast Agent for Longitudinal Assessment of Hep-2 Tumor Angiogenesis In Vivo.
Hu Q; Wang XY; Kang LK; Wei HM; Xu CM; Wang T; Wen ZH
PLoS One; 2016; 11(2):e0149075. PubMed ID: 26862757
[TBL] [Abstract][Full Text] [Related]
4. Development and Validation of a Targeted Treatment for Brain Tumors Using a Multi-Drug Loaded, Relapse-Resistant Polymeric Theranostic.
Chu W; Houston ZH; Fletcher NL; Huda P; Ahamed M; Lim TX; Day BW; Pinkham M; Thurecht KJ
Biomacromolecules; 2023 Jun; 24(6):2674-2690. PubMed ID: 37143361
[TBL] [Abstract][Full Text] [Related]
5. Novel RGD containing, temozolomide-loading nanostructured lipid carriers for glioblastoma multiforme chemotherapy.
Song S; Mao G; Du J; Zhu X
Drug Deliv; 2016 May; 23(4):1404-8. PubMed ID: 26203687
[TBL] [Abstract][Full Text] [Related]
6. Intranasal Delivery of Temozolomide-Conjugated Gold Nanoparticles Functionalized with Anti-EphA3 for Glioblastoma Targeting.
Wang L; Tang S; Yu Y; Lv Y; Wang A; Yan X; Li N; Sha C; Sun K; Li Y
Mol Pharm; 2021 Mar; 18(3):915-927. PubMed ID: 33417456
[TBL] [Abstract][Full Text] [Related]
7. Intranasal delivery of targeted polyfunctional gold-iron oxide nanoparticles loaded with therapeutic microRNAs for combined theranostic multimodality imaging and presensitization of glioblastoma to temozolomide.
Sukumar UK; Bose RJC; Malhotra M; Babikir HA; Afjei R; Robinson E; Zeng Y; Chang E; Habte F; Sinclair R; Gambhir SS; Massoud TF; Paulmurugan R
Biomaterials; 2019 Oct; 218():119342. PubMed ID: 31326657
[TBL] [Abstract][Full Text] [Related]
8. [
Provost C; Rozenblum-Beddok L; Nataf V; Merabtene F; Prignon A; Talbot JN
Mol Imaging Biol; 2019 Apr; 21(2):297-305. PubMed ID: 29948641
[TBL] [Abstract][Full Text] [Related]
9.
Cerroni B; Cicconi R; Oddo L; Scimeca M; Bonfiglio R; Bernardini R; Palmieri G; Domenici F; Bonanno E; Mattei M; Paradossi G
Heliyon; 2018 Sep; 4(9):e00770. PubMed ID: 30238062
[TBL] [Abstract][Full Text] [Related]
10. Efficient delivery of Temozolomide using ultrasmall large-pore silica nanoparticles for glioblastoma.
Janjua TI; Cao Y; Ahmed-Cox A; Raza A; Moniruzzaman M; Akhter DT; Fletcher NL; Kavallaris M; Thurecht KJ; Popat A
J Control Release; 2023 May; 357():161-174. PubMed ID: 36965857
[TBL] [Abstract][Full Text] [Related]
11. Ultrasound-triggered imaging and drug delivery using microbubble-self-aggregate complexes.
Chung IJ; Moon H; Jeon SI; Lee HJ; Ahn CH
J Biomater Sci Polym Ed; 2022 Jan; 33(1):57-76. PubMed ID: 34503403
[TBL] [Abstract][Full Text] [Related]
12. Monodispersity Increases Adhesion Efficiency and Specificity for Ultrasound-Targeted Microbubbles.
Navarro-Becerra JA; Castillo JI; Di Ruzza F; Borden MA
ACS Biomater Sci Eng; 2023 Feb; 9(2):991-1001. PubMed ID: 36153974
[TBL] [Abstract][Full Text] [Related]
13. Targeted and Synergic Glioblastoma Treatment: Multifunctional Nanoparticles Delivering Verteporfin as Adjuvant Therapy for Temozolomide Chemotherapy.
Pellosi DS; Paula LB; de Melo MT; Tedesco AC
Mol Pharm; 2019 Mar; 16(3):1009-1024. PubMed ID: 30698450
[TBL] [Abstract][Full Text] [Related]
14. Enhanced delivery of paclitaxel liposomes using focused ultrasound with microbubbles for treating nude mice bearing intracranial glioblastoma xenografts.
Shen Y; Pi Z; Yan F; Yeh CK; Zeng X; Diao X; Hu Y; Chen S; Chen X; Zheng H
Int J Nanomedicine; 2017; 12():5613-5629. PubMed ID: 28848341
[TBL] [Abstract][Full Text] [Related]
15. Concurrent blood-brain barrier opening and local drug delivery using drug-carrying microbubbles and focused ultrasound for brain glioma treatment.
Ting CY; Fan CH; Liu HL; Huang CY; Hsieh HY; Yen TC; Wei KC; Yeh CK
Biomaterials; 2012 Jan; 33(2):704-12. PubMed ID: 22019122
[TBL] [Abstract][Full Text] [Related]
16. Lipid/PLGA Hybrid Microbubbles as a Versatile Platform for Noninvasive Image-Guided Targeted Drug Delivery.
Chen Y; Liang Y; Jiang P; Li F; Yu B; Yan F
ACS Appl Mater Interfaces; 2019 Nov; 11(45):41842-41852. PubMed ID: 31633326
[TBL] [Abstract][Full Text] [Related]
17. A multifunctional theranostic contrast agent for ultrasound/near infrared fluorescence imaging-based tumor diagnosis and ultrasound-triggered combined photothermal and gene therapy.
Wang L; Lu H; Gao Q; Yuan C; Ding F; Li J; Zhang D; Ou X
Acta Biomater; 2019 Nov; 99():373-386. PubMed ID: 31525534
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of prognostic integrin α2β1 PET tracer and concurrent targeting delivery using focused ultrasound for brain glioma detection.
Chung YH; Hsu PH; Huang CW; Hsieh WC; Huang FT; Chang WC; Chiu H; Hsu ST; Yen TC
Mol Pharm; 2014 Nov; 11(11):3904-14. PubMed ID: 25153169
[TBL] [Abstract][Full Text] [Related]
19. SPIO-conjugated, doxorubicin-loaded microbubbles for concurrent MRI and focused-ultrasound enhanced brain-tumor drug delivery.
Fan CH; Ting CY; Lin HJ; Wang CH; Liu HL; Yen TC; Yeh CK
Biomaterials; 2013 May; 34(14):3706-15. PubMed ID: 23433776
[TBL] [Abstract][Full Text] [Related]
20. In vitro analysis of the trajectories of adhesive microbubbles approaching endothelial cells.
Cerroni B; Riva FR; Oddo L; Domenici F; Tortorella E; Toumia Y; Brasili F; Paradossi G
J Colloid Interface Sci; 2020 Oct; 578():758-767. PubMed ID: 32574909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
